The Cancer Vanguard
Menu
  • Cancer Vanguard
    • Our Work
  • Pharma Challenge
    • Interactive medicines optimisation and compliance dashboard
    • Analysing medicine usage data and quantifying unwarranted variation costs
    • Biosimilars adoption
  • National Cancer Strategy
  • News

News

Alliances working together to develop best practice pathways

February 28th 2018
Uncategorized

The Cancer Vanguard hosted another Communities of Practice event for Cancer Alliances, focusing on developing best practice timed pathways for colorectal, lung, prostate and upper …

Read more

Two Cancer Vanguard projects shortlisted for HSJ partnership award

January 8th 2018
Uncategorized

Two key projects recognising effective collaboration between the Cancer Vanguard and the pharmaceutical industry have been shortlisted for the HSJ Healthcare Partnership Awards 2018. The …

Read more

Bringing cancer treatments closer to home

December 18th 2017
Uncategorized

The Cancer Vanguard’s Pharma Challenge has seen us work in partnership with the pharmaceutical company Amgen to bring cancer treatments closer to home.  This project has featured …

Read more

Cancer Vanguard shines at BAC 2017

December 6th 2017
Uncategorized

There was substantial interest in the work of the Cancer Vanguard from those attending the 2017 Britain Against Cancer conference. The annual event, hosted by …

Read more

Cancer drugs project delivers benefits for patients

October 23rd 2017
Uncategorized

The Cancer Vanguard has developed a simulation modelling toolkit that can support any NHS organisation in England in the delivery of out-of-hospital denosumab (XGEVA). UCLH Cancer Collaborative led the project …

Read more

Information films guide patients through tests to diagnose blood disorders

September 4th 2017
Uncategorized

The Cancer Vanguard has produced six patient information films, subtitled into nine languages in addition to English, on the most common tests and procedures used …

Read more

Supporting biosimilar use in oncology

September 1st 2017
Uncategorized

The Cancer Vanguard medicines optimisation steering group has produced a position statement supporting the adoption and appropriate use of biosimilars in cancer patients. Trusts in …

Read more

Pharma Challenge resources improve understanding of biosimilars

August 8th 2017
Uncategorized

NHS England specialised commissioning is recommending that Trusts looking to implement biosimilars make use of the resources developed for the Cancer Vanguard Pharma Challenge. Biosimilars …

Read more

Cancer Vanguard in line for top pharmaceutical award

June 20th 2017
Uncategorized

The Cancer Vanguard’s medicines optimisation team has been shortlisted for the prestigious Team of the Year award by the Royal Pharmaceutical Society (RPS). The shortlisting …

Read more

Sharing our learning with Cancer Alliances

March 28th 2017
Uncategorized

Cancer Alliances were urged by NHS England’s National Cancer Director Cally Palmer to set the pace for change in services at the Cancer Vanguard sharing …

Read more
  • «
  • 1
  • 2
  • »
  • Privacy and cookies
© 2023 The Cancer Vanguard copyright

We use cookies to give you the best possible experience. If you continue, we’ll assume you are happy to receive the cookies we place. Privacy and cookies information.

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close